Continuous Pectoral Nerve Block in Breast Cancer Surgery

Sponsor
Antalya Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04036370
Collaborator
(none)
48
1
2
3.5
13.5

Study Details

Study Description

Brief Summary

The purpose of the study is to evaluate the effect of continuous pectoral nerve block on postoperative analgesia consumption in breast cancer surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PECS group
  • Other: Control group
N/A

Detailed Description

Pectoral nerve block has been developed as an alternative to thoracic paravertebral and/or thoracic epidural blocks in recent years. It is frequently applied for postoperative analgesia in breast cancer surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomised ControlledRandomised Controlled
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
The Effect of Continuous Pectoral Nerve Block on Postoperative Analgesia Consumption in Breast Cancer Surgery
Actual Study Start Date :
Jul 30, 2019
Actual Primary Completion Date :
Nov 15, 2019
Actual Study Completion Date :
Nov 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: PECS group

In addition to routine analgesic protocol; before anaesthesia induction; following the PECS I + II block, a continuous infusion catheter will be placed at the PECS II block level under the guidance of USG, and local anesthetic infusion will be started via the catheter at the end of the operation.

Procedure: PECS group
Pecs block performed using ultrasound guidance. Standard pain follow up and monitorization will be performed.

Sham Comparator: Control group

Peroperative and postoperative routine analgesic protocol will be performed with no additional intervention (block).

Other: Control group
Standard pain follow up and monitorization will be performed.

Outcome Measures

Primary Outcome Measures

  1. analgesia consumption [12 hours]

    postoperative 12 hours

Secondary Outcome Measures

  1. analgesia consumption [during the surgery]

    intraoperative

  2. postoperative Numeric Rating Scale (NRS) score [0, 1, 3, 6, 9, 12 hours]

    postoperative pain assessment will be performed using NRS score (NRS 0=no pain, NRS 10= most severe possible). The NRS scores will be recorded at postoperative 0, 1, 3, 6, 9, 12 hours

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • American Society of Anesthesiology (ASA) I-II

  • 18-65 years

  • Body mass index (BMI) ≤40 kg/m2

  • Elective breast cancer surgery

Exclusion Criteria:
  • ASA ≥4

  • under 18 years of age or over 65 years of age

  • declining to give written informed consent

  • history of allergy to the local anesthetics

  • contraendications of peripheral block or local anesthetic infiltration (local infection, coagulopathy, etc)

  • history of breast surgery

  • treatment due to psychiatric disorder

  • history of treatment for chronic pain

  • history of nerve blocks in order to treat postoperative pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation Antalya Turkey 07100

Sponsors and Collaborators

  • Antalya Training and Research Hospital

Investigators

  • Principal Investigator: Arzu Karaveli, Antalya TRH

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Arzu Karaveli, University of Health Sciences Antalya Training and Research Hospital, Antalya Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04036370
Other Study ID Numbers:
  • 13/21
First Posted:
Jul 29, 2019
Last Update Posted:
Nov 18, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Arzu Karaveli, University of Health Sciences Antalya Training and Research Hospital, Antalya Training and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2019